Clinical Trial Update: Study of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy [Phase 4]

View source ↗

Summary

A Phase 4 trial of ipragliflozin in patients with type 2 diabetes mellitus receiving insulin therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Ipragliflozin (Suglat) (ipragliflozin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED